Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ji, Qing
NCT04766307: A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2	Recruiting	4	1100	RoW	Interleukin-2, IL-2	Beijing Chest Hospital	Tuberculosis, Pulmonary	12/21	12/21